Category: Zacks Small Cap Research

12345820 / 578 POSTS
By John Vandermosten, CFANASDAQ:HTBXREAD THE FULL HTBX RESEARCH REPORTSecond Quarter 2019 Results Heat Biologics, Inc. (NASDAQ:HTBX) reported second quarter 2019 results in an August 14 release and concurrently submitted the companion 10-Q to the SEC ...
By John Vandermosten, CFAOTC:GOVXGeoVax Labs, Inc. (OTC:GOVX) filed its second quarter 2019 10-Q and issued the accompanying press release on August 14, 2019 providing an operational and financial update on the company’s performance. During the secon ...
By John Vandermosten, CFANASDAQ:PHIOREAD THE FULL PHIO RESEARCH REPORTPhio Pharmaceuticals Corp. (NASDAQ:PHIO) reported second quarter 2019 results and filed its Form 10-Q on August 12, 2019. Since the beginning of the year, the company has announced ...
By John Vandermosten, CFANASDAQ:AZRXREAD THE FULL AZRX RESEARCH REPORTAzurRx BioPharma, Inc. (NASDAQ:AZRX) filed its 2019 second quarter 10-Q with the SEC for the three month period ending June 30, 2019 along with a press release providing a corporat ...
By Ian Gilson, PhD, CFANASDAQ:UHALREAD THE FULL UHAL RESEARCH REPORTOn August 22, 2019, AMERCO (NASDAQ:UHAL) held its annual virtual presentation to stockholders, analysts and investors. The presentation covered the current financial conditions and a ...
By Brian Marckx, CFANASDAQ:MNKD | NASDAQ:UTHRREAD THE FULL MNKD RESEARCH REPORTQ2 2019 Update: Record Revenue, Margins as Rx Continue to Ramp. Clinical Evidence Driving Adoption…Financial UpdateMannKind Corp (NASDAQ:MNKD) reported financial results f ...
By John Vandermosten, CFANASDAQ:TTNPREAD THE FULL TTNP RESEARCH REPORTSecond Quarter 2019 Financial and Operational ResultsDespite several factors in its favor including global expansion and repeat patients, second quarter revenues for Titan Pharmace ...
By John Vandermosten, CFANASDAQ:VVUSREAD THE FULL VVUS RESEARCH REPORTSecond Quarter 2019 ResultsVivus, Inc. (NASDAQ:VVUS) released second quarter results on August 6, 2019 and provided an update of financial and operational results for the April to ...
By John Vandermosten, CFANASDAQ:LPCNREAD THE FULL LPCN RESEARCH REPORTSecond Quarter 2019 Operational and Financial ResultsOn August 7, 2019 Lipocine (NASDAQ:LPCN) filed its 2Q:19 10-Q and posted its earnings release for the three month period ending ...
By John Vandermosten, CFANASDAQ:DYAIREAD THE FULL DYAI RESEARCH REPORTSecond Quarter 2019 Financial & Operational Results Dyadic International Inc. (NASDAQ:DYAI) released second quarter 2019 financial and operational results on August 13, 2019. R ...
12345820 / 578 POSTS